IDWEEK ON-DEMAND 2025: THE COMPLETE INFECTIOUS DISEASES LIBRARY
“Advancing Science, Improving Care: The Global ID Authority”
Conference Dates: October 8 – 12, 2025 Location: Atlanta, GA, USA (Georgia World Congress Center) Academic Hosts: IDSA, SHEA, HIVMA, PIDS, and SIDP
General Information
IDWeek is not just a conference; it is the annual benchmark for the field of Infectious Diseases. It represents the combined intellectual power of the five major ID societies.
The On-Demand 2025 package is designed for the busy clinician who cannot be in five places at once. It transforms the chaotic live event into a structured, searchable Medical Course. This digital library grants you unlimited access to over 200 sessions, ensuring you never miss a pivotal update—from the “late-breaking” clinical trials to the granular debates on antibiotic dosing.
Target Audience
This comprehensive curriculum is mandatory for:
Infectious Disease Physicians: Who need to interpret the 2025 guidelines for multi-drug resistant organisms (MDROs).
Clinical Pharmacists: Especially those specializing in stewardship and PK/PD dynamics of new agents (cefiderocol, plazomicin, etc.).
Infection Preventionists: Dealing with hospital-acquired outbreaks and policy implementation.
General Practitioners & Hospitalists: Who manage complex infections on the wards and need “Cheat Sheets” for empiric therapy.
Learning Objectives
By engaging with the IDWeek 2025 content, participants will be able to:
Combat Resistance: Apply the latest IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (2025 Updates).
Modernize HIV Care: Transition eligible patients to Long-Acting Injectable antiretroviral regimens and implement Doxy-PEP for STI prevention.
Navigate the “Tripledemic”: Master the co-management of COVID-19, Influenza, and RSV in both pediatric and adult populations.
Debunk Dogma: Evaluate the evidence behind “Shorter is Better” courses of therapy for pneumonia, bacteremia, and osteomyelitis.
Course Topics & Tracks (2025 Highlights)
TOPIC 1: The “Superbug” Summit (AMR)
New Drug Pipeline: Clinical data on the newest beta-lactam/beta-lactamase inhibitors.
Phage Therapy: Moving from experimental compassionate use to clinical trials.
Fungal Resistance: Managing Candida auris outbreaks in 2025.
TOPIC 2: HIV & Sexual Health
PrEP 3.0: Ultra-long-acting agents and implants.
Doxy-PEP: Implementation guidelines, resistance concerns, and real-world efficacy data.
Aging with HIV: Managing metabolic syndrome and cardiovascular risk in long-term survivors.
TOPIC 3: Clinical Controversies (The “Great Debates”)
Interactive Sessions where experts argue opposing sides:
“Oral vs. IV for Endocarditis: Have we gone too far?”
“Is Vancomycin dead for MRSA bacteremia?”
“Do we really need to treat asymptomatic bacteriuria in any population?”
TOPIC 4: Pediatric Focus (PIDS Track)
Congenital Syphilis: The rising crisis and management strategies.
Vaccine Hesitancy: New communication scripts for pediatricians.
RSV Prevention: Real-world data on the effectiveness of nirsevimab and maternal vaccination.
TOPIC 5: Diagnostic Stewardship
Rapid Diagnostics: Interpreting BioFire/PCR panels in hours, not days.
The “Culture-Negative” Patient: How to use Metagenomic Next-Generation Sequencing (mNGS) effectively without breaking the budget.





Reviews
There are no reviews yet.